Ergönül, Ö. Crimean–Congo haemorrhagic fever. Lancet Infect. Dis. 6, 203–214 (2006).
Hawman, D. W. & Feldmann, H. Crimean–Congo haemorrhagic fever virus. Nat. Rev. Microbiol. 21, 463–477 (2023).
Feng, J. et al. Discovery of a macrocyclic influenza cap-dependent endonuclease inhibitor. J. Med. Chem. 67, 2570–2583 (2024).
Tchesnokov, E. P., Bailey-Elkin, B. A., Mark, B. L. & Götte, M. Independent inhibition of the polymerase and deubiquitinase activities of the Crimean–Congo hemorrhagic fever virus full-length L-protein. PLoS Negl. Trop. Dis. 14, e0008283 (2020).
Welch, S. R. et al. Identification of 2′-deoxy-2′-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus. Antiviral Res. 147, 91–99 (2017).
Muzammil, K. et al. Recent advances in Crimean-Congo hemorrhagic fever virus detection, treatment, and vaccination: overview of current status and challenges. Biol. Proced. Online 26, 20 (2024).
Fanelli, A. & Buonavoglia, D. Risk of Crimean Congo haemorrhagic fever virus (CCHFV) introduction and spread in CCHF-free countries in southern and Western Europe: a semi-quantitative risk assessment. One Health 13, 100290 (2021).
Malet, H., Williams, H. M., Cusack, S. & Rosenthal, M. The mechanism of genome replication and transcription in bunyaviruses. PLoS Pathog. 19, e1011060 (2023).
Gerlach, P., Malet, H., Cusack, S. & Reguera, J. Structural insights into bunyavirus replication and its regulation by the vRNA promoter. Cell 161, 1267–1279 (2015).
Arragain, B. et al. Pre-initiation and elongation structures of full-length La Crosse virus polymerase reveal functionally important conformational changes. Nat. Commun. 11, 3590 (2020).
Arragain, B. et al. Structural snapshots of La Crosse virus polymerase reveal the mechanisms underlying Peribunyaviridae replication and transcription. Nat. Commun. 13, 902 (2022).
Kouba, T. et al. Conformational changes in Lassa virus L protein associated with promoter binding and RNA synthesis activity. Nat. Commun. 12, 7018 (2021).
Peng, R. et al. Structural insight into arenavirus replication machinery. Nature 579, 615–619 (2020).
Liu, L. et al. Structure basis for allosteric regulation of lymphocytic choriomeningitis virus polymerase function by Z matrix protein. Protein Cell 14, 703–707 (2023).
Kang, H. et al. Structural basis for recognition and regulation of arenavirus polymerase L by Z protein. Nat. Commun. 12, 4134 (2021).
Williams, H. M. et al. Structural snapshots of phenuivirus cap-snatching and transcription. Nucleic Acids Res. 52, 6049–6065 (2024).
Wang, P. et al. Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation. Nat. Microbiol. 5, 864–871 (2020).
Vogel, D. et al. Structural and functional characterization of the severe fever with thrombocytopenia syndrome virus L protein. Nucleic Acids Res. 48, 5749–5765 (2020).
Williams, H. M. et al. Structural insights into viral genome replication by the severe fever with thrombocytopenia syndrome virus L protein. Nucleic Acids Res. 51, 1424–1442 (2023).
Wang, X. et al. Structure of Rift Valley fever virus RNA-dependent RNA polymerase. J. Virol. 96, e0171321 (2022).
Keown, J. R., Carrique, L., Nilsson-Payant, B. E., Fodor, E. & Grimes, J. M. Structural characterization of the full-length Hantaan virus polymerase. PLoS Pathog. 20, e1012781 (2024).
Durieux Trouilleton, Q., Barata-García, S., Arragain, B., Reguera, J. & Malet, H. Structures of active Hantaan virus polymerase uncover the mechanisms of Hantaviridae genome replication. Nat. Commun. 14, 2954 (2023).
Durieux Trouilleton, Q., Housset, D., Tarillon, P., Arragain, B. & Malet, H. Structural characterization of the oligomerization of full-length Hantaan virus polymerase into symmetric dimers and hexamers. Nat. Commun. 15, 2256 (2024).
Meier, K. et al. Structural and functional characterization of the Sin Nombre virus L protein. PLoS Pathog. 19, e1011533 (2023).
Li, J. et al. Structural basis for the activation of plant bunyavirus replication machinery and its dual-targeted inhibition by ribavirin. Nat. Plants 11, 518–530 (2025).
Tipih, T. et al. Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection. Antiviral Res. 218, 105703 (2023).
Wang, Q. et al. In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean–Congo hemorrhagic fever virus. Antiviral Res. 199, 105273 (2022).
Liu, K. et al. Discovery of baloxavir sodium as a novel anti-CCHFV inhibitor: biological evaluation of in vitro and in vivo. Antiviral Res. 227, 105890 (2024).
Reich, S. et al. Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature 516, 361–366 (2014).
Xue, L. et al. Cryo-EM structures of Thogoto virus polymerase reveal unique RNA transcription and replication mechanisms among orthomyxoviruses. Nat. Commun. 15, 4620 (2024).
Krischuns, T. et al. The host RNA polymerase II C-terminal domain is the anchor for replication of the influenza virus genome. Nat. Commun. 15, 1064 (2024).
Neriya, Y. et al. A comprehensive list of the Bunyavirales replication promoters reveals a unique promoter structure in Nairoviridae differing from other virus families. Sci. Rep. 12, 13560 (2022).
Holm, T. et al. Biochemical and structural studies reveal differences and commonalities among cap-snatching endonucleases from segmented negative-strand RNA viruses. J. Biol. Chem. 293, 19686–19698 (2018).
Omoto, S. et al. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Sci. Rep. 8, 9633 (2018).
Kumar, G., Cuypers, M., Webby, R. R., Webb, T. R. & White, S. W. Structural insights into the substrate specificity of the endonuclease activity of the influenza virus cap-snatching mechanism. Nucleic Acids Res. 49, 1609–1618 (2021).
Kuang, W. et al. Structure and function of the nairovirus cap-snatching endonuclease. Nucleic Acids Res. 54, gkaf1515 (2026).
Cao, W. et al. Efficacy and safety of WXSH0208 tablets in treatment of acute uncomplicated influenza infection in adults: a multicenter randomized, double-blind, placebo-controlled phase 2 trial. J. Infect. Dis. 232, 441–449 (2025).
ter Horst, S. et al. Enhanced efficacy of endonuclease inhibitor baloxavir acid against orthobunyaviruses when used in combination with ribavirin. J. Antimicrob. Chemother. 75, 3189–3193 (2020).
Loutan, A. J. et al. Bunyaviral cap-snatching endonuclease activity and inhibition with baloxavir-like inhibitors in the context of full-length L proteins. Viruses 17, 420 (2025).
Yin, Y. W. & Steitz, T. A. The structural mechanism of translocation and helicase activity in T7 RNA polymerase. Cell 116, 393–404 (2004).
Kirschberg, T. A. et al. Discovery of a 2′-fluoro-2′-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable properties. Bioorg. Med. Chem. Lett. 27, 1840–1847 (2017).
Yin, W. et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science 368, 1499–1504 (2020).
Sala, F. A., Ditter, K., Dybkov, O., Urlaub, H. & Hillen, H. S. Structural basis of Nipah virus RNA synthesis. Nat. Commun. 16, 2261 (2025).
Smee, D. F., Jung, K.-H., Westover, J. & Gowen, B. B. 2′-Fluoro-2′-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models. Antiviral Res. 160, 48–54 (2018).
Welch, S. R. et al. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems. Antiviral Res. 136, 9–18 (2016).
Kumaki, Y., Day, C. W., Smee, D. F., Morrey, J. D. & Barnard, D. L. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections. Antiviral Res. 92, 329–340 (2011).
Yu, P. et al. 2′-Fluoro-2′-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705. Arch. Virol. 165, 2605–2613 (2020).
Bajramovic, J. J., Volmer, R., Syan, S., Pochet, S. & Gonzalez-Dunia, D. 2′-Fluoro-2′-deoxycytidine inhibits Borna disease virus replication and spread. Antimicrob. Agents Chemother. 48, 1422–1425 (2004).
Xu, Y., Groaz, E., Rihon, J., Herdewijn, P. & Lescrinier, E. Synthesis, antiviral activity, and computational study of β-d-xylofuranosyl nucleoside phosphonates. Eur. J. Med. Chem. 255, 115379 (2023).
Murakami, E. et al. Mechanism of activation of β-d-2′-deoxy-2′-fluoro-2′-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase. Antimicrob. Agents Chemother. 51, 503–509 (2007).
Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169–4185 (2021).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Cryst. D 60, 2126–2132 (2004).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Cryst. D 66, 213–221 (2010).
Pettersen, E. F. et al. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
Kabsch, W. XDS. Acta Cryst. D 66, 125–132 (2010).
Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Cryst. D 67, 235–242 (2011).
McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658–674 (2007).
